These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1366 related articles for article (PubMed ID: 31068988)

  • 21. Estimates of cancer incidence and mortality in Europe in 1995.
    Bray F; Sankila R; Ferlay J; Parkin DM
    Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can the Mediterranean diet prevent prostate cancer?
    Itsiopoulos C; Hodge A; Kaimakamis M
    Mol Nutr Food Res; 2009 Feb; 53(2):227-39. PubMed ID: 19051189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database.
    Stephenson RA
    Urol Clin North Am; 2002 Feb; 29(1):173-81. PubMed ID: 12109343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer epidemiology.
    Plata Bello A; Concepcion Masip T
    Arch Esp Urol; 2014 Jun; 67(5):373-82. PubMed ID: 24914835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age at diagnosis and age at death in familial prostate cancer.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who bears the greatest burden of aggressive treatment of indolent prostate cancer?
    Mahal BA; Cooperberg MR; Aizer AA; Ziehr DR; Hyatt AS; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Orio PF; Trinh QD; Nguyen PL
    Am J Med; 2015 Jun; 128(6):609-16. PubMed ID: 25644324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.
    Brawley OW
    Cancer; 1997 Nov; 80(9):1857-63. PubMed ID: 9351560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in breast cancer by race and ethnicity.
    Ghafoor A; Jemal A; Ward E; Cokkinides V; Smith R; Thun M
    CA Cancer J Clin; 2003; 53(6):342-55. PubMed ID: 15224974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
    Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common cancers in the elderly.
    Hansen J
    Drugs Aging; 1998 Dec; 13(6):467-78. PubMed ID: 9883401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
    Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
    Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
    Hoffman RM; Meisner AL; Arap W; Barry M; Shah SK; Zeliadt SB; Wiggins CL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):259-63. PubMed ID: 26646364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population-Level Patterns of Prostate Cancer Occurrence: Disparities in Virginia.
    Adebola TM; Fennell HWW; Druitt MD; Bonin CA; Jenifer VA; van Wijnen AJ; Lewallen EA
    Curr Mol Biol Rep; 2022 Mar; 8(1):1-8. PubMed ID: 35909818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of Prostate and Testicular Cancer.
    Filippou P; Ferguson JE; Nielsen ME
    Semin Intervent Radiol; 2016 Sep; 33(3):182-5. PubMed ID: 27582605
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.